|1.||Hammock, Bruce D: 107 articles (12/2015 - 02/2002)|
|2.||Morisseau, Christophe: 54 articles (12/2015 - 02/2002)|
|3.||Hwang, Sung Hee: 22 articles (12/2015 - 01/2009)|
|4.||Imig, John D: 22 articles (01/2015 - 02/2002)|
|5.||Yang, Jun: 20 articles (12/2015 - 01/2009)|
|6.||Kim, In-Hae: 14 articles (12/2015 - 04/2004)|
|7.||Tsai, Hsing-Ju: 14 articles (12/2015 - 05/2005)|
|8.||Inceoglu, Bora: 14 articles (12/2015 - 11/2006)|
|9.||Alkayed, Nabil J: 14 articles (09/2015 - 12/2007)|
|10.||Liu, Jun-Yan: 13 articles (12/2015 - 01/2009)|
09/01/2015 - "Peroxisomal translocation of soluble epoxide hydrolase protects against ischemic stroke injury."
01/01/2014 - "Mechanism of protection by soluble epoxide hydrolase inhibition in type 2 diabetic stroke."
05/01/2008 - "Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans."
12/01/2007 - "Soluble epoxide hydrolase: a novel therapeutic target in stroke."
10/01/2005 - "We investigated the association of polymorphisms in the soluble epoxide hydrolase gene (EPHX2) with incident ischemic stroke in African-Americans and Whites. "
01/30/2013 - "Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models."
07/21/2015 - "A recently identified, nonchannel, nonneurotransmitter therapeutic target for pain is the enzyme soluble epoxide hydrolase (sEH). "
09/01/2011 - "The soluble epoxide hydrolase as a pharmaceutical target for pain management."
10/14/2010 - "1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain."
05/01/2015 - "Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain."
01/01/2012 - "Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney."
11/01/2008 - "Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo."
01/01/2010 - "Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury."
04/15/2015 - "Soluble epoxide hydrolase (sEH) has been demonstrated to be a key enzyme involved in the pathologic development of several cardiovascular diseases and inflammation, and inhibition of sEH is therefore very helpful or crucial for the treatment of ischemia-reperfusion injury, cardiac hypertrophy, hypertension and inflammation. "
08/01/2015 - "Soluble Epoxide Hydrolase Pharmacological Inhibition Ameliorates Experimental Acute Pancreatitis in Mice."
10/01/2014 - "Soluble epoxide hydrolase deficiency ameliorates acute pancreatitis in mice."
01/01/2014 - "Effects of soluble epoxide hydrolase deficiency on acute pancreatitis in mice."
|5.||Lung Neoplasms (Lung Cancer)
05/01/2000 - "Although the three published results for Caucasians are somewhat variable, the association among African-Americans in these data provides some support for the hypothesis that genetically reduced microsomal epoxide hydrolase activity may be protective against lung cancer."
03/01/2015 - "Inconsistent association of microsomal epoxide hydrolase (mEH) polymorphisms (Tyr113His, His139Arg) and lung cancer susceptibility have been reported in earlier studies. "
09/01/2010 - "The aim of this study was to investigate the relationship between EPHXI exon 3 Tyr113His and exon 4 His139Arg polymorphisms, predicted microsomal epoxide hydrolase (mEH) activity, and lung cancer development. "
05/01/2002 - "To investigate the role of microsomal epoxide hydrolase (mEH) polymorphisms in the aetiology of lung cancer and to assess the interaction between mEH polymorphisms and smoking, we performed a meta-analysis of seven published studies, which included 2078 cases and 3081 controls, and a pooled analysis of eight studies (four published and four unpublished at that time) with a total of 986 cases and 1633 controls. "
06/01/2001 - "This study evaluated the influence of genetic polymorphisms in the microsomal epoxide hydrolase (mEPHX) gene on lung cancer risk in a case-control study of two different ethnic groups, Mexican-Americans and African-Americans. "
|2.||Arachidonic Acid (Vitamin F)
|3.||Benzoic Acid (Ucephan)
|9.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|10.||Glutathione Transferase (Glutathione S-Transferase)
|1.||Surgical Instruments (Clip)
|3.||Cardiopulmonary Resuscitation (CPR)